Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.90
Bid: 17.90
Ask: 18.70
Change: -0.25 (-1.35%)
Spread: 0.80 (4.469%)
Open: 18.10
High: 18.10
Low: 17.90
Prev. Close: 18.55
LMS Live PriceLast checked at -
LMS Capital is an Investment Trust

To achieve absolute total returns over the medium to longer term, principally through capital gains and supplemented with the generation of a longer term income yield, by investing primarily in private equity.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investor/Analyst Meeting and Deal Update

9 Sep 2010 15:00

9 September 2010

LMS Capital plc - Investor/Analyst Meeting and Deal Update

LMS Capital plc today held a meeting for investors and analysts setting out the Board's medium term strategy for the business, including presentations on certain investee companies. The slide presentation is available on LMS Capital's website, www.lmscapital.com.

In addition, the Company is pleased to announce the following:

San Francisco Equity Partners Acquires Zoom Eyeworks

San Francisco Equity Partners ("SFEP"), the private equity firm in which LMS Capital is the majority partner, has acquired Zoom Eyeworks, Inc. a leading designer of innovative, expressive eyewear products. The change in ownership provides Zoom Eyeworks with the financial and strategic resources to capitalise on the growing demand for its brands.

Based in Berkeley, CA, Zoom is one of the largest providers of non-prescription reading glasses in the U.S., with a product portfolio consisting of reading glasses, sunglasses and accessories. Zoom's brands, which include Zoom, Dr. Dean Edell and ICU, are sold in approximately 15,000 locations throughout the drug, food, convenience and speciality retail channels. Zoom's products emphasize fashion, style and quality and offer a wide range of alternatives to traditional reading glasses for every occasion. ICU is one of the fastest-growing and best-known brands of fashion reading eyewear in the U.S. and has received Oprah Magazine's "O" pick multiple times. For more information please visit www.zoomeyeworks.com.

SFEP has already built pre-eminent consumer brands including Method Products, the world's most innovative natural homecare brand, and Yes To, the industry's fastest-growing natural personal care brand.

Further details about the acquisition, and SFEP, are available at www.sfequitypartners.com.

Glenn Payne, Chief Executive Officer of LMS Capital, said:

"SFEP has a great track record of building companies and turning what are perceived as consumer products into unique brands that drive considerable mass market appeal. With SFEP's guidance, industry relationships and financial resources, we foresee a very bright future for Zoom."

For further information please contact:

LMS Capital plc 020 7935 3555Glenn Payne, Chief Executive OfficerTony Sweet, Chief Financial OfficerBrunswick Group LLP 020 7404 5959Simon SporborgLeonora BurtenshawAbout LMS Capital

LMS Capital is an investment company with over 30 years' experience in private equity and development capital investment. Our objective is to deliver superior absolute returns for shareholders through a portfolio of direct investments; our focus is on small to medium sized companies in our preferred sectors of consumer and media, energy & utilities and applied technology, software & services.

We seek to partner with experienced managers in profitable, growing companies where we expect to be able to add value. Our focus is on buying and investing in management teams and companies at favourable prices: on the assumption of gradual economic improvement our outlook is positive on the investment environment and we expect M&A activity to increase accordingly. We will continue to be cautious in our investment approach, aiming to grow our investments (and NAV) by 15%+ per annum without undue risk or investing in unproven businesses.

The Company has a 30 year history and a new investment team; this history means it has a portfolio at 30 June 2010 valued at £230.3 million, most of which we expect to realise in cash in the medium term. This harvesting of our legacy investments should produce the capital required to finance a number of new direct deals over the next five years.

Our recent deal experience has confirmed to us that potential partners place great store on working with people who not only understand their business (typically through previous deals in the same sector) but also have themselves worked in operational management positions and who therefore understand and empathise with the role of management in a business partnership. All members of our investment team have prior experience as part of an operational management team.

vendor
Date   Source Headline
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23
23rd May 20234:03 pmRNSDividend Declaration - REPLACEMENT
18th May 20234:08 pmRNSDividend Declaration
18th May 20234:03 pmRNSResult of AGM
5th May 20237:00 amRNSStatement re Notice to shareholders
28th Apr 20237:00 amRNSFirst Quarter 2023 Update
24th Apr 20232:42 pmRNSNotice of AGM
24th Apr 20232:37 pmRNSNotice of AGM
14th Apr 202310:47 amRNSHolding(s) in Company
22nd Mar 20233:04 pmRNSHolding(s) in Company
20th Mar 20237:00 amRNSFinal Results fo rthe Year Ended 31 December 2022
7th Feb 20237:00 amRNSNet Asset Value(s)
25th Nov 20223:54 pmRNSHolding(s) in Company
28th Oct 20227:00 amRNSThird Quarter 2022 Update
2nd Aug 20227:09 amRNSHalf year Report and Dividend declaration
19th May 20223:42 pmRNSDividend Declaration
18th May 20224:27 pmRNSResult of AGM
27th Apr 20227:00 amRNSFirst Quarter 2022 Update
22nd Apr 20227:00 amRNSNotice of Annual General Meeting 2022
10th Mar 20227:00 amRNSFinal Results for the Year Ended 31 December 2021
31st Jan 20227:00 amRNSNAV Estimate as at 31 December 2021
15th Dec 20214:41 pmRNSSecond Price Monitoring Extn
15th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSPortfolio Update
12th Nov 202112:34 pmRNSPortfolio Update
22nd Oct 20217:00 amRNSThird Quarter 2021 Update
23rd Sep 202112:16 pmRNSHolding(s) in Company
4th Aug 20217:00 amRNSDividend Declaration
3rd Aug 20217:00 amRNSHalf-year Report
8th Jul 202110:16 amRNSChange of Registered Office
18th May 20214:36 pmRNSPrice Monitoring Extension
13th May 20213:32 pmRNSFinal Dividend for the year ended 31 December 2020
12th May 20214:20 pmRNSResult of AGM
29th Apr 20217:00 amRNSFirst Quarter 2021 Update
9th Apr 20217:00 amRNSAnnual Financial Report
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:35 pmRNSPrice Monitoring Extension
12th Mar 20217:09 amRNSFinal Results for the Year Ended 31 December 2020
2nd Mar 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.